Trial site
NeuroBehavioral Medicine Group
- 6running trials
- 8closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Autism4 trials
- Depression4 trials
- Bipolar disorder2 trials
- Alzheimer disease1 trial
- Insomnia1 trial
- Schizophrenia1 trial
- Tourette syndrome1 trial
- Phase
- Phase 37 trials
- Phase 26 trials
- Phase 41 trial
- Status
- Completed8 trials
- Recruiting5 trials
- Active, not recruiting1 trial
- Lead sponsor
- Intra-Cellular Therapies, Inc.3 trials
- MapLight Therapeutics2 trials
- Boehringer Ingelheim1 trial
- Bristol-Myers Squibb1 trial
- Cingulate Therapeutics1 trial
- and 6 more
Running trials
Recruiting
Recruiting
Recruiting
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Recruiting
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
Recruiting
Active, not recruiting
ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Autism2 recruiting
- Bipolar disorder2 recruiting
- Alzheimer disease1 recruiting
- Schizophrenia1 recruiting
Closed trials
Completed
Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients
Completed
Completed
Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301
Completed
Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults
Completed
Completed
ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026